NEW TREATMENT TARGETS NATURAL TEARS FOR DRY EYES
TradingMarkets.com
ORONTO, Nov. 25, 2010 (Canada NewsWire via COMTEX) --
RESTASIS(®)(1) is Now Approved by Health Canada for the Treatment of Dry Eye Disease
Allergan is pleased to announce that Health Canada has approved RESTASIS(®) (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease ("Dry Eye"). RESTASIS(®) is the first prescription eye drop to target the underlying cause of chronic Dry Eye.
No comments:
Post a Comment